Prof. MD. Mehmet Parlak

Education and Specialization

• Atatürk University, Faculty of Medicine, Professor
  
• Kafkas University, Faculty of Medicine, Professor
  
• Atatürk University, Faculty of Medicine, Associate Professor
  
• Atatürk University, Faculty of Medicine, Assistant Professor
  
• Atatürk Hospital, Infectious Diseases and Clinical Microbiology Specialist
  
• Atatürk University, Faculty of Medicine, Doctor
  

Experience

• 2006-2009 Kafkas University/Faculty of Medicine/Department of Internal Medicine/Department of Infectious Diseases and Clinical Microbiology, Founding Dean
  

Professional Memberships

• Turkish Infectious Diseases and Clinical Microbiology Specialist Association (EKMUD)
  
• Viral Hepatitis Control Association (VHSD),
  
• Turkish Clinical Microbiology and Infectious Diseases Association (KLİMİK)
  

Awards

• 2009 Good Administrator, Kafkas University

Research and Publications

Patent

• Half antibody (fab) with the fc part removed for medical use[cite: 1]. Inventor: Mehmet Özen[cite: 1]. No: 2016/0910[cite: 1]. Examined patent[cite: 1].
• Scientific Studies

A. Publications in International Journals within the Scope of SCI Expanded

Original Articles

• Özen M, Civriz Bozdağ S, Çakmak G, Topçuoğlu P, Eroğlu AH, Gündüz M, Arslan Ö, Demirer T, Akan H, İlhan O, Beksaç M, Gürman G, Özcan M. Antilymphocyte/thymocyte globulin for the treatment of steroid-refractory acute graft-versus-host disease: 20-year experience at a single center[cite: 3]. UHOD:2015; 25: 236-244[cite: 4].
  
• Özen E, Özen M, Çiledağ N, Kabar F, Gündüz M, Arıbaş BK. Splenic malignant lesions in lymphoma and solid tumors, a comparative study of imaging techniques[cite: 5]. UHOD: 2015; 25: 081-087[cite: 6].
  
• Ozen M, Ates O, Babacan T, Sever AR, Akin S, Ozisik Y, Altundag K. Trastuzumab 1-Year vs 9-Week in Early Stage Her2 Positive Lymph Node Negative Breast Cancer Patients[cite: 7]. JBUON. 2016 Jul-Aug;21(4):799-808[cite: 7].
  
• Ozen M, Yilmaz G, Coskun B, Topcuoglu P, Ozturk B, Gunduz M, Atilla E, Arslan O, Ozcan M, Demirer T, Ilhan O, Konuk N, Balık I, Gurman G, Akan H. A quasi-experimental study analyzing the effectiveness of portable HEPA filters in preventing infections in hematology patients during construction[cite: 8]. Turk J Hematol 2016;33:41-47 [cite: 8]
  
• Özen M, Üstün C, Öztürk B, Topçuoğlu P, Arat M, Gündüz M, Atilla E, Bolat G, Arslan Ö, Demirer T, Akan H, İlhan O, Beksaç M, Gürman G, Özcan M. Allogeneic Transplantation In Chronic Myeloid Leukemia And The Effect Of Tyrosine Kinase Inhibitors On Survival, A Quasi-Experimental Study[cite: 9]. Turk J Haematol. 2017 Mar 1;34(1):16-26[cite: 10].
  
• Ozen M, Gunduz M, Topcuoglu P, Toprak SK, Dalva K, Gurman G, Ilhan O. The Effect of Age on Peripheral Stem Cell Mobilization in Healthy Donors, Single Center Experience[cite: 11]. J Clin Apher. 2017 Feb;32(1):16-20[cite: 11].
  
• Gündüz M, Ozen M, Sahin U, Toprak SK, Civriz Bozdag S, Kurt Yuksel M, Arslan O, Ozcan M, Demirer T, Beksac M, Ilhan O, Gurman G. Topcuoglu P. Subsequent Malignancies After Allogeneic Hematopoietic Stem Cell Transplantation[cite: 12]. Clin Transplant. 2017 Jul;31(7)[cite: 12].
  
• E Gündüz, HM Durgun, M Gündüz, M Özen. Standard blood parameters in anemic patients with cancer and with other diseases[cite: 13]. Biomedical Research 2017; 28 (18): 7955-7959 [cite: 14]
  
• Özen M, Yılmaz S, Özkan T, Özer Y, Pekel AA, Sunguroğlu A, Gürman G, Arslan Ö. Incomplete Antibodies May Reduce ABO Cross-match Incompatibility. A Pilot Study[cite: 15]. Turk J Haematol. 2018 Mar 1;35(1):54-60[cite: 16].
  
• Atilla E, Yalciner M, Atilla PA, Ates C, Bozdag SC, Yuksel MK, Toprak SK, Gunduz M, Ozen M, Akan H, Demirer T, Arslan O, Ilhan O, Beksac M, Ozcan M, Gurman G, Topcuoglu P. Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients? [cite: 17] Antivir Ther. 2018; 23 (8): 647-653[cite: 17].
  
• Cekdemir D, Güvenç S, Özdemirkıran F,,,et al, Özen M,…et al, Diz Küçükkaya R. A Multi-Center Study on the Efficacy of Eltrombopag in Management of Refractory Chronic Immune Thrombocytopenia: A Real-Life Experience[cite: 18]. Turk J Haematol. 2019; 36 (4): 230 [cite: 18]
  
• Antioxidant and inflammatory biomarkers in Herpes Zoster[cite: 19]..Oskay T, Keskin C, Özen M. J Med Virol. 2022 Apr 14. doi: 10.1002/jmv.27781[cite: 19].

Non-Original SCI Expanded Publications:

• Altundag K, Bulut N, Tezcan E, Ozen M, Purnak T. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates? [cite: 20] J Oral Maxillofac Surg. 2007 Jan;65(1):154[cite: 20].
• Ozen M, Karaahmet F, Aydin K, Sarici F, Altundag K. Bisphosphonates may also be effective in the management of non-skeletal metastases in hormone receptor positive breast cancer[cite: 21]. Med Hypotheses. 2007;68(3):714[cite: 21].
• Ozen M, Karaahmet F, Tezcan ME, Bulut N, Altundag K. Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer's disease[cite: 22]. Med Hypotheses. 2007;68(1):231-2[cite: 22].
• Altundag K, Tezcan ME, Ozen M, Karaahmet F, Bulut N. Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression[cite: 23]. Med Hypotheses. 2007;68(1):235[cite: 23].
• Kav T, Ozen M, Uner A, Abdullazade S, Ozseker B, Bayraktar Y. How confocal laser endomicroscopy can help us in diagnosing gastric lymphomas? [cite: 24] Bratisl Lek Listy. 2012;113(11):680-2 [cite: 24]
• Ozen M, Keskin O, Topçuoğlu P, Oztürk B, Özgül S, Ilgen U, Küçükşahin O, Turgay M, Törüner M, Gürman G. Autoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients? [cite: 25] Leuk Lymphoma. 2014 Jul;55(7):1697-8[cite: 25].
  
• Ozen M, Haznedaroglu IC. As a Rare Presentation of Waldenstrom’s Macroglobulinemia; Fever[cite: 26]. UHOD:2014, 24, 221-222 [cite: 26]
• Özen M, Erkul S, Alptekin Erkul GS, Genç Ö, Akgül E, Vural AH. Therapeutic Plasma Exchange Ameliorates Incompatible Crossmatchs[cite: 27]. Turk J Haematol. 2016;33:356-358[cite: 27].
• Erkus E, Kocak MZ, Aktas G, Ozen M, Atak BM, Duman TT, Tekce BK, Savli H. A Rare Non-Hemolytic Case of Idiopathic Cold Agglutinin Disease[cite: 28]. Clin Lab. 2018 Jun 1;64(6):1075-1078. doi: 10.7754/Clin.Lab.2018.180114[cite: 28].
• Leg Ulcers Associated with Anagrelide[cite: 29]. Oskay T, Özen M. Turk J Haematol. 2021 Dec 7;38(4):338-340 [cite: 29]

B. Publications in International Journals Outside the Scope of SCI Expanded

• Özen M, Kalyoncu U. SAPHO syndrome may be treated effectively with combined drug regimens - A case report[cite: 30]. International Journal of Case Reports and Images 2011;2(1):8-11[cite: 30].
  
• Beyler O, Özen M, Ergün İ. Early graft survival after renal transplantation, single center experince[cite: 31]. Experimental Biomedical Research. 2020; 3 (2), 71-78 [cite: 31]

C. Publications in National Journals

• Özen M, Pepedil F, Cengiz M, Kılıçkap S, Aksoy S, Türker A, Kars A. Lung cancer in young patients under the age of thirty-five; single center experience[cite: 33]. Acta Oncol Tur. 2012; 45 (1):1-4 [cite: 33]
  
• Yılmaz G, Çiftçioğlu A, Gündüz M, Özen M, Sarıcaoğlu EM, Akan H. Evaluation of Agent Distribution and Risk Factors in Hematologic Cancer Patients with Candidemia[cite: 34]. Klimik Dergisi 2015; 28: 117-121 [cite: 34]
  
• Gündüz M, Yılmaz G, Sarıcaoğlu EM, Özen M, Ayhan M, Akan H. Cell Phones as a Source of Infection in a Hematology Clinic[cite: 35]. LLM Dergi 2017;1(1):5-9 [cite: 35]
  
• Özen M, Azap A, Gürman G, Akan H. Protective Measures Taken in the Department of Hematology During Construction[cite: 36]. Ankara Üniversitesi Tıp Fakültesi Mecmuası 2016, 69 (3):167-171[cite: 36].
  
• M Gündüz, ŞM Bakanay, S Yaman, A Usta, M Özen, A Şentürk Yıkılmaz, S Küçükyurt Kaya, S Doğan, S Akıncı, İ Dilek. Prevalence and Current Management of Perianal Diseases in Acute Leukemia Patients[cite: 37]. ORTADOĞU TIP DERGİSİ 2018;10 (4): 454-459 [cite: 37]
  
• Özen M. Letter to the Editor[cite: 38]. Nobel Medicus. 2016. 34;12(1):110 [cite: 38]
  
• Gündüz M, Özen M, Yüksel S, Kaygusuz G, Kuzu I, Demirer T. Hairy Cell Leukemia Presenting with Isolated Bone Lesions[cite: 39]. LLM Dergi 2017;1(1):14-17[cite: 39].
  
• Hajıyev C, Oğuz AK, Özen M, Düzgün N. Coexistence of Rarities: Development of Chronic Myelomonocytic Leukemia During the Course of Necrotizing Sarcoid Granulomatosis[cite: 40]. LLM Dergi 2017;1(1):22-25[cite: 40].,

D. Oral Presentation Presented at International Congresses

• M. Beksac, P. Topcuoglu, M. Gunduz, P. Ataca, S. M. Bakanay Ozturk, B. Kirazli, M. Merter, M. Ozen, N. O. Kucuk, E. Ozkan. Upgrade Of FDG-PET Response Following Autologous Stem Cell Transplantation Is Associated With Better Progression Free Survival Among Patients With Multiple Myeloma[cite: 41]. Abstract no: O030. S18-19. 41st EBMT Annual Meeting. 22-25 Mart 2015. İstanbul[cite: 42].

E. Poster Presentations Presented at International Congresses

• M. Ozen, S. Aksoy, O. Dizdar, D. Sener Dede, E. Dogan, C. Arslan, I. H. Gullu, M. K. Altundag; Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis[cite: 44]. J Clin Oncol 28, 2010 (15_suppl; abstr e13664) [cite: 45]
• B Ayhan, K Dalva, S Ipek, D Ozu, A Ugurbilgin, M Ozen, D Ozel Demiralp, M Beksac. A Fourier Transform Infrared Spectroscopic Investigations on the Molecular Profiling of Multiple Myeloma[cite: 46]. 17th Congress of EHA 14-17 June 2012 Amsterdam, The Netherland. Abstract No:1489 sayfa:592 | haematologica | 2012; 97(s1) 2012 [cite: 47]
• P. Topcuoglu, M. Ozen, M. Ozcan, O. Ilhan, M. Beksac, N. Konuk, G. Gurman, O. Arslan. The outcome of allogeneic haematopoetic stem cell transplantation in adult patients older than 50 years[cite: 49]. poster no:P790. Sayfa no:130. 39th Annual Meeting of the EBMT 8 April 2013 London, UK [cite: 50]
• M Ozen, O Keskin, O Kucuksahin, U Ilgen, P Topcuoglu, M Turgay, M Toruner, G Gurman. Tumor necrosis factor inhibitors and acute leukemia in two cases[cite: 51]. Leukemia e18010 J Clin Oncol 31, 2013 (suppl; abstr e18010)[cite: 51]. 2013 ASCO Annual Meeting[cite: 52].
• G Gurman, M Ozen, G Yilmaz, B Coskun, P Topcuoglu, B Ozturk, M Ozcan, O Arslan, O Ilhan, M Beksac, I Balık, H Akan; Hepa systems in hematology clinic to ameliorate the increased fungal infection risk owing to environmental changing[cite: 53]. Leukemia e18009 J Clin Oncol 31, 2013 (suppl; abstr e18009)[cite: 54]. 2013 ASCO Annual Meeting[cite: 55].
• M Ozcan, B Ozturk, M Ozen, P Topcuoglu, M Arat, O Arslan, O Ilhan, H Akan, M Beksac, N Konuk, G Gurman; Comparison of allogeneic stem cell transplantations in chronic myeloid leukemia before and after the era of tyrosine kinase inhibitors[cite: 56]. Allogeneic Bone Marrow 7038 J Clin Oncol 31, 2013 (suppl; abstr 7038)[cite: 57]. 2013 ASCO Annual Meeting[cite: 58].
• T Demirer, S Baslar, VA Uysal, M Beksac, M Ozen, N Konuk, O Ilhan, O Arslan, M Ozcan, P Topcuoglu, G Gurman. Comparison Of Flow Cytometric and Clinical Findings In Patients With Paroxysmal Nocturnal Hemoglobinuria[cite: 59]. Blood 2013 122 (21):4877 [cite: 60]
• E Ayyıldız, M Özen, M Bay, Y Yıldırım, N Kaplan, O Ilhan. LDL APHERESIS: THE COMPARISON OF TWO DEVICES [cite: 61] 2014 ASFA & WAA Joint Meeting in San Francisco, California[cite: 61]. Abstract no: 72 [cite: 62]
• Topcuoglu P, Gunduz M., Ozen M., Atilla E., Arslan O., Ozcan M., Akan H., Beksac M., Gurman G. THE APPLICATION OF SECOND TIME ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION: REASONS AND OUTCOME[cite: 63]. 2014 EBMT meeting (Milan, Italy). PH-P344 [cite: 63]
• Topcuoglu P, Koksoy EB., Ozen M., Arslan O., Ozcan M., Konuk N., Akan H., Beksac M., Gurman G. RISK FACTORS FOR THE DEVELOPMENT OF INVASIVE FUNGAL INFECTION IN PATIENTS UNDERGOING ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION[cite: 64]. 2014 EBMT meeting (Milan, Italy). PH-P469. Mar 2014; 49 (Supplement 1s) 40th Annual Meeting of the European Group for Blood and Marrow Transplantation: S1 - S593 [cite: 64]
• Gurman G, Atilla E, Ozen M, Kubilay P, Yilmaz G, Gunduz M, Arslan O, Ozcan M, Demirer T, Akan H, Ilhan O, Beksac M, Topcuoglu P. Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation[cite: 65]. BBMT. 2014; 20,2, Suppl S194–S195. 2014 BMT Tandem Meetings[cite: 65].
• E Atilla, U Sahin, P Ataca, A Uslu, E Kircali, B Atesagaoglu, G Pekcan, M Merter, M Gunduz, M Ozen, S Civriz Bozdag, SK Toprak, P Topcuoglu, O Arslan, T Demirer, H Akan, G Gurman, M Beksac, O Ilhan, N Konuk, M Ozcan. Is R-CODOX-M/IVAC Inferior to Other Regimens in Burkitt’s Lymphoma: A Single Center Experience[cite: 66]. Blood 2014 124:21:5448. 56th ASH Annual Meeting[cite: 66]. 6-9/12/2014[cite: 67].
• M Beksac, M Gunduz, M Ozen, SM Bakanay Ozturk, O Kucuk, E Ozkan. Impact of PET-CT Response on Survival Parameters Following Autologous Stem Cell Transplantation Among Patients with Multiple Myeloma: Comparison of Two Cut-Off Values[cite: 68]. Blood 2014 124:3983 [cite: 69]
• G Gurman, M Merter, P Ataca, M Ozen, B Atesagaoglu, M Gunduz, G Pekcan, U Sahin, SK Toprak, P Topcuoglu, M Ozcan, O Ilhan, E Atilla. The Efficacy of Tyrosine Kinase Inhibitors with Steroid As First Line Induction Therapy in Ph+ Acute Lymphoblastic Leukemia[cite: 70]. Blood 2014 124:5281 [cite: 71]
• P Topcuoglu, M Gunduz, M Ozen, S Civriz Bozdag, SK Toprak, O Arslan, M Ozcan, T Demirer, O Ilhan, H Akan, M Beksac, N Konuk, G Gurman. Treatment Approaches in Acute Leukemia Patients Relapsing Following Allogeneic Hematopoietic Stem Cell Transplantation[cite: 72]. Blood 2014 124:5891 [cite: 73]
• M Gunduz, P Ataca, M Ozen, E Atilla, S Civriz Bozdag, SK Toprak, P Topcuoglu, M Ozcan, T Demirer, M Beksac, H Akan, G Gurman, O Ilhan, N Konuk, O Arslan. Do FMS-like Tyrosine Kinase 3 and Nucleophospmin 1 Gene Mutations Really Effect Survival in Acute Myeloid Leukemia ? [cite: 74] Blood 2014 124:5328 [cite: 75]
• P. Topcuoglu, M. Gunduz, M. Ozen, E. Atilla, P. Ataca, S. Civriz Bozdag, S. K. Toprak, M. Kurt Yuksel, O. Arslan, M. Ozcan, T. Demirer, O. Ilhan, H. Akan, M. Beksac, N. Konuk, A. Uysal, G. Gurman. The relapse in acute leukemia after the allogeneic hematopoetic stem cell transplantation: No approaches have been superior yet[cite: 76]. Abstract no: P722. S478. 41st EBMT Annual Meeting. 22-25 Mart 2015. İstanbul[cite: 77].
• Akcora Yildiz D, Ozkan T, Yukselten Y, Turkel Sesli N, Ozkanca S, Gunduz M, Ozen M, Beksac M, Sunguroglu A. Lomeguatrib, a O6-Methylguanine-DNA-Methyltransferase (MGMT) Inhibitor, Induces DNA Damage Induced Apoptosis By Targeting Double-Strand DNA Repair in Multiple Myeloma[cite: 78]. San Diego, ABD. 3-6 Aralık 2016, Poster No: 2103[cite: 78].
• D Cekdemir, F Ozdemirkiran, S Guvenc, A Eser, V Ozkocaman, H Haydaroglu Sahin, E Ermis Turak, E Kara, M Comert, S Sadri, M Aslaner, B Uncu Ulu, A Karakus, DS Bapur, D Aydin, I Alacacioglu, A Tekinalp, S Namdaroglu, F Ceran, P Tarkun, D Kiper, M Cetiner, M Yenerel, EG Umit, G Yilmaz, H Terzi, E Atilla, UY Malkan, K Acar, E Ozturk, A Tombak, C Sunu, O Salim, N Alayvaz, O Sayan, U Ozan, M Ayer, Z Gokgoz, N Andic, E Kizilkilic, F Noyan, M Ozen, F Pepedil Tanrikulu, G Alanoglu, HA Ozkan, V Aslan, G Cetin, A Akyol Erikci, B Deveci, F Ersoy Dursun, H Dermenci, OM Akay Yanar, D Ozatli, L Undar, EN Tiftik, A Turkoz, G Sucak, I Haznedaroglu, M Ozcan, M Sencan, AM Demir, M Tombuloglu, G Ozet, O Bilgir, B Turgut, MA Ozcan, KB Payzin, M Sonmez, O Ayyildiz, MS Dal, S Ertop, T Soysal, E Kaya, R Eser, A Unal, M Pehlivan, T Tuglular Firatli, G Saydam, R Diz Kucukkaya. Use Of Eltrombopag In Immune Thrombocytopenia In Turkey[cite: 80]. 24th Biennial International Congress on Thrombosis. Istanbul, Turkey[cite: 80]. 4-7 Mayıs 2016. No: C-0261[cite: 81].
• M Özen, P Topçuoğlu, G Çakmak, AH Eroğlu, Ö Arslan, O İlhan, N Konuk, M Beksaç, G Gürman, M Özcan. Anti-Thymocyte Globuline (ATG) or Anti-Lymphocyte Globuline (ALG) For Treatment of Steroid Refractory Acute Graft Versus Host Disease (GvHD)[cite: 83]. 4th International Congress on Leukemia Lymphoma Myeloma. 22-25 Mayıs 2013 İstanbul[cite: 84]. Sayfa:363, Poster no:177[cite: 85].
• G Cengiz Seval, P Topçuoğlu, M Özen, Ö Arslan, G Gürman, A Uysal, M Özcan. Clinical FeAtures and Treatment of Splenic Marginal zone lymphoma[cite: 86]. 4th International Congress on Leukemia Lymphoma Myeloma. 22-25 Mayıs 2013 İstanbul[cite: 86]. Sayfa: 346. Poster no: 146[cite: 87].
• H Ilgin-Ruhi, A Vicdan, M Ozen, O Ilhan, G Gurman. Evaluation of complex karyotype in a patient with myelodysplastic syndrome[cite: 88]. CHROMOSOME RESEARCH 21, S102-S102 [cite: 89]
• Mesenchymal Stem Cell Infusion in Haploidentical Hematopoietic Stem Cell Transplantation in Patients with Hematological Malignancies[cite: 90]. Onder Arslan, Ayse Eser Elcin, Erden Atilla, Sukran Seker, Pinar Baydin, Mehmet Gunduz, Mehmet Ozen, Ulas Darda Bayraktar, Osman Ilhan, Meral Beksac, Yasar Murat Elcin, Gunhan Gurman[cite: 90]. Biology of Blood and Marrow Transplantation 24 (3), S178-S179 [cite: 91]
• Ekin Kircali, Guldane Cengiz, Sevgi Çolak, Mehmet Gunduz, Pinar Ataca Atilla, Erden Atilla, Mehmet Özen, Muhit Ozcan, Meral Beksac. Comparison of Two Alkylating Agents Among Refractory Multiple Myeloma: Published and Our Retrospective Bendamustine Combination Experience with Melflufen As Single Agent[cite: 92]. 2020/11/5. Blood. 136:13-14[cite: 93].

F. Invited Talk at a National Scientific Event

• Mehmet Özen. Approach to Hematologic Emergencies[cite: 94]. Dutbat Emergency Cases Approach Days Internal Emergencies Symposium. March 28, 2015. Kütahya [cite: 94]
• Mehmet Özen. Current Status in ITP Diagnosis and Treatment[cite: 95]. 3rd Bozyaka Hematology Symposium. November 13-15, 2015. Kuşadası[cite: 95].
• Mehmet Özen. The Role of Transplantation in Bone Marrow Failures[cite: 96]. 4th Black Sea Hematology Symposium[cite: 96]. June 29 – July 1, 2018. Sheraton Hotel, Samsun[cite: 96].
• Mehmet Özen. Bcl-2 inhibitors in other hematological malignancies[cite: 97]. “5th Hematological Oncology Congress” [cite: 97] September 20 – September 22, 2018. Acapulco Resort Hotel, TRNC[cite: 97].
• Mehmet Özen. Preoperative evaluation in hematology[cite: 98]. 5th Black Sea Hematology Congress[cite: 98]. June 28- 30, 2019. Sheraton Grand Hotel, Samsun[cite: 98].
• Mehmet Özen. Fluid Electrolyte Imbalance in Stem Cell Transplantation[cite: 99]. 11th Bone Marrow Transplantation and Apheresis Nursing Education Program. March 1-2, 2019. Xanadu Hotel, Antalya[cite: 99].
• Mehmet Özen. Role of FLT3 Inhibitors in AML Treatment[cite: 100]. 2nd Hematological Rare Diseases Congress. February 7-10, 2019. Concorde Luxury Resort Hotel, TRNC [cite: 100]

G. Oral Presentations at National Congresses

• M Ozen, F Pepedil, S Aksoy, A Türker, A Kars. Retrospective Analysis of Young (≤35 years) Lung Cancer Patients[cite: 102]. 3rd Medical Oncology Congress. March 24-28, 2010. S31[cite: 102]. Ref. No:165 [cite: 103]
• M Özen, G Yılmaz, B Coşkun, P Topçuoğlu, B Öztürk, İ Balık, H Akan, G Gürman. Application of High-Efficiency Particulate Air Filter System and Efficacy of Antifungal Prophylaxis in Preventing Infections in Hematology Patients in a Changing Environment[cite: 104]. XXXVIII. National Hematology Congress. October 31 – November 3, 2012. Antalya. Abstract:0645 S-11 [cite: 105]
• B Öztürk, M Özen, P Topçuoğlu, M Arat, Ö Arslan, O İlhan, H Akan, M Beksaç, N Konuk, G Gürman. Comparative Evaluation of Allogeneic Stem Cell Transplantations in CML Before and After the Tyrosine Kinase Inhibitor (TKI) Era[cite: 107]. XXXVIII. National Hematology Congress. October 31 – November 3, 2012. Antalya Abstract:0648 S-32 [cite: 108]
• EB Köksoy, C Ateş, M Özen, Ö Arslan, M Özcan, N Konuk, H Akan, M Beksaç, G Gürman, P Topçuoğlu. Risk Factors for Fungal and Cytomegalovirus (CMV) Infection Development in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (Allo-HSCT)[cite: 110]. 39th National Hematology Congress[cite: 110]. October 23-26, 2013, Antalya. Book of Abstracts. Pages: 30-32. Abstract No: 0479 [cite: 111]
• M Özen, G Yılmaz, B Coşkun, P Topçuoğlu, B Öztürk, M Gündüz, E Atilla, Ö Arslan, M Özcan, T Demirer, O İlhan, N Konuk, İ Balık, H Akan, G Gürman. Prevention of Hematological Infections That May Occur During Construction[cite: 113]. Infectious Diseases World Workshop. March 20-23, 2014, Ankara[cite: 113]. S21[cite: 114].
• Gunduz M, Ozen M, Civriz Bozdag S, Toprak SK, Arslan O, Ozcan M, Demirer T, Ilhan O, Akan H, Beksac M, Konuk N, Gurman G, Topcuoglu P. Approaches to Relapse after Transplantation in Acute Leukemias[cite: 115]. 40th National Hematology Congress. October 2014. Antalya. SS10. Abstract 0540. S:16 [cite: 115]
• Gunduz M, Ataca P, Ozen M, Akfırat H, Atilla E, Civriz Bozdag S, Toprak SK, Topcuoglu P, Ozcan M, Demirer T, Beksac M, Akan H, Gurman G, Ilhan O, Konuk N, Arslan O. The Effect of FMS-like Tyrosine Kinase 3 and Nucleophosmin 1 Gene Mutations on Survival in Acute Myeloid Leukemia[cite: 116]. 40th National Hematology Congress. October 22-25, 2014. Antalya. SS45. Abstract 0563. S:18-19 [cite: 117]
• Atilla E, Sahin U, Ataca P, Uslu A, Kırcalı E, Atesagaoglu B, Pekcan G, Merter M, Gunduz M, Ozen M, Civriz Bozdag S, Toprak SK, Topcuoglu P, Arslan O, Demirer T, Akan H, Gurman G, Beksac M, Ilhan O, Konuk N, Ozcan M. Is R-CODOX-M/IVAC Really Superior to Other Treatment Regimens in Burkitt's Lymphoma? [cite: 118] Single Center Experience[cite: 118]. 40th National Hematology Congress. October 2014. Antalya. SS42[cite: 118]. Abstract 0591[cite: 119].
• Beksac M, Gunduz M, Ozen M, Bakanay Ozturk SM, Kucuk O, Ozkan E. Impact of PET Response on Survival Indicators Following ASCT in Patients with Multiple Myeloma: Comparison Results of Two Different Cut-off Values[cite: 120]. 40th National Hematology Congress. October 2014. Antalya. SS55. Abstract 0621[cite: 120].
• Colak S, Ataca P, Atilla E, Gunduz M, Ozen M, Beksac M. Our Treatment Results with Bendamustine-Containing Regimens in Multiple Myeloma Patients Who Developed Resistance to Proteasome Inhibitor and Immunomodulatory Drugs[cite: 121]. 40th National Hematology Congress. October 2014. Antalya. SS60[cite: 121]. Abstract 0365[cite: 122].
• Çınarsoy M, Demiriz I, Özen M, Tekgündüz AİE, Altuntaş F. Comparison of Dana Farber and HyperCVAD protocols in acute lymphoblastic leukemia patients under 40 years of age[cite: 123]. 41st National Hematology Congress. October 21-24, 2015. Antalya. Abstract 502[cite: 123].
• Çekdemir D, Özdemirkıran F, Güvenç S, Eser A, Özkocaman V, Haydaroğlu Şahin H, Ermiş Turak E, Kara E, Cömert M, Sadri S, et al, Özen M, et al. Use of Eltrombopag in Immune Thrombocytopenia in Our Country[cite: 125]. 41st National Hematology Congress. October 21-24, 2015. Antalya[cite: 125]. Abstract 354. S:8-9 [cite: 126]
• M Özen, T Özkan, S Yılmaz, Y Özer, A Sunguroğlu, G Gürman, Ö Arslan. Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility. A Pilot Study[cite: 127]. X.National Blood Centers and Transfusion Medicine Congress. March 12 – 16, 2017. Antalya. S-01[cite: 128].
• Önder Arslan, Ayşe Eser Elçin, Erden Atilla, Şükran Şeker, Pınar Baydın, Mehmet Gündüz, Mehmet Özen, Ulaş Darda Bayraktar, Osman İlhan, Meral Beksaç, Yaşar Murat Elçin, Günhan Gürman. Mesenchymal Stem Cell Application in Haploidentical Stem Cell Transplantations in Patients with Hematological Malignancies[cite: 129]. 43rd National Hematology Congress[cite: 129]. 2017. Antalya [cite: 130]
• Ozlem Ozen , Mesuda Falay , Zehra Narli Ozdemir , Mehmet Ozen , Ali Fettah , Sule Yesil , Simten Dagdas , Gulsum Ozet. A Novel Marker Cd317 In Patıents Wıth Cd34 Negatıve B-Cell Acute Lymphoblastıc Leukemıa[cite: 131]. ICLLM. 2019 [cite: 131]

H. Poster Presentations at National Congresses

• M Ozen, S Aksoy, Ö Dizdar, D Dede, E Doğan, Ç Arslan, İ Güllü, K Altundağ. Addition of 9 Weeks of Trastuzumab to Adjuvant Chemotherapy in Early Stage Her2-positive Breast Cancer Patients: Retrospective Evaluation[cite: 133]. 3rd Medical Oncology Congress[cite: 133]. March 24-28, 2010. P112. Ref. No:35 [cite: 134]
• GS Guven, M Ozen. The “Heavy” Face of Diamond: Diamond Grinding as an Occupational Disease Related to Heavy Metal[cite: 135]. 12th National Internal Medicine Congress. October 6-10, 2010. P115 [cite: 135]
• GS Güven, M Ozen. Pronator Syndrome and Systemic Lupus Erythematosus: Seen “Together” for the First Time[cite: 136]. 12th National Internal Medicine Congress[cite: 136]. October 6-10, 2010. P081 [cite: 137]
• M Özen, H Uzun, AE Aksu, GS Guven. Prolidase Deficiency in Preoperative Evaluation: What Should the “Adult’s Doctor” Do? [cite: 138] 12th National Internal Medicine Congress. October 6-10, 2010. P116 [cite: 138]
• Erbay MÇ, Tekgündüz E, Çimentepe M, Akay N, İskender G, Tetik A, Özen M, Koçubaba Ş, Yüksel M, Altuntaş F. Bacterial Agents and Quinolone Resistance in Hematological Cancer Patients with Bacteremia[cite: 139]. 15th Turkish Clinical Microbiology and Infectious Diseases Congress 2011, Antalya, Poster: P10-01 (page 265) [cite: 139]
• M Özen, P Topçuoğlu, O Küçükşahin, B Öztürk, S Özgül, M Törüner, M Turgay, G Gürman. Development of Acute Leukemia in Two Cases Receiving Anti-Tumor Necrosis Factor (Anti-TNF) and Azathioprine Treatment[cite: 140]. XXXVIII. National Hematology Congress[cite: 140]. October 31 – November 3, 2012. Antalya Abstract:0635 P-022 [cite: 141]
• P Topçuoğlu, M Özen, O İlhan, G Gürman. Sensitivity to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation: Two Case Reports[cite: 142]. XXXVIII. National Hematology Congress[cite: 142]. October 31 – November 3, 2012. Antalya. Abstract:0396 P-252 [cite: 143]
• M Özen, G Yılmaz, P Topçuoğlu, İ Balık, G Gürman, KO Memikoğlu, M Beksaç, H Akan. H1N1 Epidemic and its Control in the Stem Cell Transplantation Unit[cite: 144]. 10th Febrile Neutropenia Symposium May 17-19, 2013. Ankara Poster no:“P18” [cite: 144]
• B Coşkun, H Ünal, G Yılmaz, S Kaymakçı, M Özen, O Memikoğlu, H Akan, H Kurt. Hospital Infections Developed in a Hematology Clinic in One Year[cite: 145]. 10th Febrile Neutropenia Symposium May 17-19, 2013 Ankara Poster no: P02 [cite: 145]
• G Yılmaz, M Özen, A Çiftçioğlu, G Gürman, H Kurt, H Akan. Candida Species Isolated from Blood Cultures in a Hematology Clinic over a Seven-Year Period[cite: 146]. 10th Febrile Neutropenia Symposium May 17-19, 2013 Ankara Poster no:P12 [cite: 147]
• E Atilla, M Özen, P Kubilay, M Gündüz, Ö Arslan, M Özcan, T Demirer, H Akan, O İlhan, M Beksaç, N Konuk, G Gürman, P Topçuoğlu. Development and Management of Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation[cite: 149]. 39th National Hematology Congress. October 23-26, 2013, Antalya[cite: 149]. Book of Abstracts. Pages: 83-84. Abstract no:0560 [cite: 150]
• M Gündüz, M Özen, E Atilla, I Kuzu, T Demirer. Hairy Cell Leukemia with Isolated Bone Involvement, A Case Report[cite: 151]. 39th National Hematology Congress. October 23-26, 2013, Antalya[cite: 151]. Book of Abstracts. Page: 99 Abstract:0567[cite: 152].
• M Gündüz, B Çağlar, M Özen, E Atilla, I Kuzu, O İlhan. Blastic Plasmacytoid Dendritic Cell Leukemia as a Rare Case[cite: 153]. 39th National Hematology Congress. October 23-26, 2013, Antalya. Book of Abstracts[cite: 153]. Pages: 124-125 Abstract:0568[cite: 154].
• M Özen, P Topçuoğlu, K Dalva, E Ayyıldız, O İlhan, G Gürman. The Importance of Recount in Unrelated Transplants[cite: 155]. 39th National Hematology Congress. October 23-26, 2013, Antalya. Book of Abstracts[cite: 155]. Page: 153 Abstract:0563 [cite: 156]
• M Gündüz, M Özen, E Atilla, M Özcan. A Chronic Myeloproliferative Disease with Acute Onset, Case Report[cite: 157]. 39th National Hematology Congress. October 23-26, 2013, Antalya. Book of Abstracts[cite: 157]. Page: 250 Abstract:0565 [cite: 158]
• P Topçuoğlu, M Gündüz, M Özen, E Atilla, Ö Arslan, M Özcan, H Akan, M Beksaç, G Gürman. Reasons and Outcomes for Second Allogeneic Hematopoietic Stem Cell Transplantation[cite: 159]. 8th National Bone Marrow Transplantation and Stem Cell Therapies Congress[cite: 160]. March 06-08, 2014, Antalya Presentation:0137 P-007 [cite: 161]
• M Özen, A Peker, E Bulut, S Bilgiç, P Topçuoğlu. Vesical Artery Embolization in the Treatment of Refractory Hemorrhagic Cystitis, A Case Report[cite: 162]. 8th National Bone Marrow Transplantation and Stem Cell Therapies Congress[cite: 162]. March 06-08, 2014, Antalya. Presentation:0172 P-019 [cite: 163]
• G Cengiz Seval, P Topçuoğlu, M Özen, M Gündüz, E Atilla, K Dalva, Ö Arslan, M Özcan, T Demirer, O İlhan, N Konuk, M Beksaç, G Gürman. The Effect of HLA Compatibility in Unrelated Allogeneic Hematopoietic Cell Transplantation - Single Center Experience[cite: 165]. 8th National Bone Marrow Transplantation and Stem Cell Therapies Congress / March 06-08, 2014, Antalya[cite: 166]. Presentation:0140 P-063 [cite: 167]
• Gunduz M, Ozen M, Topcuoglu P, Toprak SK, Dalva K, Gurman G, Ilhan O. The Effect of Advanced Age on Peripheral Blood Stem Cell Mobilization in Healthy Donors[cite: 168]. 40th National Hematology Congress. October 22-25, 2014. Antalya. TP-044. Abstract:0217[cite: 168].
• Topcuoglu P, Ozen M, Gunduz M, Civriz Bozdağ S, Toprak SK. Activity of MTOR Inhibitor Sirolimus and Histone Deacetylase (HDAC) Inhibitor Vorinostat in a Patient with Refractory Hodgkin Lymphoma[cite: 169]. 40th National Hematology Congress[cite: 169]. October 2014. Antalya. P-259. Abstract:0625 [cite: 170]
• Çınarsoy M, Tetik A, Özen M, Tekgündüz AİE, Altuntaş F. Investigation of the effect of cell subtype on induction response with HyperCVAD in adult acute lymphoblastic leukemia patients[cite: 171]. 41st National Hematology Congress. October 2015. Antalya. Abstract 436. P-004 [cite: 171]
• M Seyit, S Şahin, M Özen, S Ergen Dibeklioğlu. Therapeutic Plasma Exchange in Amitriptyline Poisoning[cite: 172]. 11th National Emergency Medicine Congress. April 2015. Antalya[cite: 172]. PS 0178 [cite: 173]
• K Onbaşı, T Paşalı Kilit, S Üçgün, SÖ Erez, M Özen. What Can Undiagnosed Diabetes Lead to? [cite: 174] Acute Pancreatitis Due to Hypertriglyceridemia Secondary to Diabetes and its Treatment with Plasmapheresis[cite: 174]. 37th Turkey Endocrinology and Metabolic Diseases Congress, May 6-10, 2015, Antalya[cite: 175].
• P Korkmaz, S Erarslan, SÖ Erez, M Özen, C Uyar, A Özmen. Thrombotic Thrombocytopenic Purpura Developing After Diarrhea: Case Report[cite: 176]. 6th Tepecik Infection Days Symposium[cite: 176]. P-46. 04-08 NOVEMBER 2015. DALAMAN, MUĞLA [cite: 177]
• GS Alptekin Erkul, S Erkul, M Özen, E Akgül, AH Vural. Therapeutic Plasma Exchange Before Coronary Bypass Surgery: Case Report[cite: 178]. 14th Congress of the Turkish Society of Cardiovascular Surgery. Belek, Antalya[cite: 178]. 3-6 November 2016[cite: 179].
• P Korkmaz, S Erarslan, M Özen. An H1N1 Case with ARDS[cite: 180]. 6th Turkey EKMUD Congress. Belek, Antalya[cite: 180]. May 11-15, 2016. PS-249[cite: 180].
• AK Oğuz, M Özen, N Düzgün. Coexistence of Rarities: Chronic Myelomonocytic Leukemia Developing in the Course of Necrotizing Sarcoid Granulomatosis[cite: 181]. XXXIII. National Allergy and Clinical Immunology Congress. Bodrum. October 8-12, 2016. P:211[cite: 181].
• Mehmet Zahid Koçak, Mehmet Özen, Buket Tekçe, Edip Erkuş, Gülali Aktaş, Burçin Meryem Atak, Tuba Taslamacıoğlu Duman, Haluk Şavlı. Idiopathic Cold Agglutinin Disease[cite: 182]. 2017. 43rd National Hematology Congress. Titanic Deluxe Belek Hotel, Antalya[cite: 182].
• Zehra Karaman, Uğur Şahin, Mustafa Merter, Mehmet Gündüz, Mehmet Özen,Meral Beksaç. Ankara University Faculty of Medicine Multiple Myeloma Elotuzumab And Immunomodulatory Drug Treatment Experience[cite: 183]. 2017. 43rd National Hematology Congress[cite: 183]. Titanic Deluxe Belek Hotel, Antalya[cite: 184].
• U Şahin, M Gündüz, M Merter, Z Narlı Özdemir, M Özen, S Civriz Bozdağ, M Kurt Yüksel, SK Toprak, Ö Arslan, M Özcan, T Demirer, O İlhan, H Akan, M Beksaç, G Gürman, P Topçuoğlu. Management and Prognosis of Acute Myeloid Leukemia Relapse After Allogeneic Hematopoietic Stem Cell Transplantation[cite: 186]. 10th National Bone Marrow Transplantation and Cellular Therapies Congress. March 1-3, 2018 – ANTALYA. P20[cite: 187]. S126-127[cite: 188].
• Özen M, İfran A, Aksoyoğlu İ, Ural AU. Full Match Allogeneic Stem Cell Transplantation from Grandson to Grandfather[cite: 189]. October 30- November 2, 2019. 45th National Hematology Congress. Titanic Deluxe Belek Hotel, Antalya[cite: 189]. P492[cite: 190].
• Ekin Kırcalı, Güldane Cengiz Seval, Sevgi Çolak, Mehmet Gündüz, Mehmet Özen, Pınar Ataca Atilla, Erden Atilla, Muhit Özcan, Meral Beksaç. Retrospective Evaluation of Bendamustine Efficacy in R/R Multiple Myeloma Patients and Comparison with Melflufen[cite: 191]. 46th National Hematology Congress[cite: 191]. Titanic Deluxe Belek Hotel, Antalya. 2020 [cite: 192]

I. Translations

• ” Özen M. I. Leukemia 2. Adult Acute Myeloid Leukemia [cite: 193].”p:15-33[cite: 193]. . ISSUU - Md Anderson Medical Oncology[cite: 193]. Translation Editors: Fikri İçli, Nurdan Taçyıldız, Diclehan Kılıç[cite: 194]. Nobel Tıp Kitabevi, 2013. ISBN: 978-0-07-170106-8 [cite: 194]
• “Özen M, Aydın T. I. Leukemia 4. Chronic Myeloid Leukemia [cite: 195].”p:53-75[cite: 195]. . ISSUU - Md Anderson Medical Oncology[cite: 195]. Translation Editors: Fikri İçli, Nurdan Taçyıldız, Diclehan Kılıç[cite: 196]. Nobel Tıp Kitabevi, 2013. ISBN: 978-0-07-170106-8 [cite: 196]
• “Özen M, Ak S. XII. Palliative Care and Symptom Management 48. Pain Management and Symptom Control[cite: 197].” P:1301-133[cite: 197]. Chapters. ISSUU - Md Anderson Medical Oncology[cite: 198]. Translation Editors: Fikri İçli, Nurdan Taçyıldız, Diclehan Kılıç. Nobel Tıp Kitabevi, 2013. ISBN: 978-0-07-170106-8 [cite: 198]
• Altuntaş F, Özen M. Clinical Case Solutions Hematology[cite: 199]. Case 22. 68-year-old male patient has headache and confusion[cite: 199]. Translation Editor: Mustafa Çetin[cite: 200]. Nobel Kitabevi, 2012. ISBN: 9786053971207 [cite: 200]
• Mehmet Özen. Spleen[cite: 201]. Postgraduate Hematology[cite: 201]. Translation from 7th Edition[cite: 201]. Chapter 17. Translation Editor: Oral Nevruz[cite: 201].
• Mehmet Özen, Canan Hajıyev. Chronic myeloid leukemia[cite: 202]. Chapter 13. Translation of Clinical Manual of Blood and Bone Marrow Transplantation [cite: 202]
• Mehmet Özen, Cantürk Kaya. Chapter 30 immune deficiencies[cite: 203]. Translation of Clinical Manual of Blood and Bone Marrow Transplantation [cite: 203]
• Mehmet Özen. Relationship tests[cite: 204]. Modern blood banking book[cite: 204].

J. Reviewing in Journals within the Scope of SCI Expanded

• Reviewing for Medical Science Monitor journal for the article "Protective role of grape seed proanthocyanidins against CCl4 induced acute liver injury in mice" [cite: 205]
• Reviewing for Medical Science Monitor journal for the article "Iron excretion with urine in patients with the risk of acute kidney injury after cardiac surgery" [cite: 206]
• Reviewing for Turkish Journal of Hematology journal for the article "Rapid progression of blastic plasmacytoid dendritic cell neoplasm without extracutaneous manifestation" [cite: 207]
• Reviewing for Turkish Journal of Hematology journal for the article "Association Of Killer-Cell Immunoglobulin-Like Receptor Gene Polymorphisms With Clinical Features And Prognosis Of Turkish Chronic Lymphocytic Leukemia Patients[cite: 208]. Do KIR Polymorphisms Influence CLL Outcome?" [cite: 208]
• Reviewing for non-SCI journal for the article "Post-Transplant Lymphoproliferative Disease: A Retrospective Review Between 2008 and 2012 at Ipo Porto"[cite: 209]. (Porto Biomedical Journal) [cite: 209]. 2017 [cite: 209]
• Reviewing for Turkish Journal of Hematology journal for the article "Multiple Myeloma in Brain Parenchyma" [cite: 210]
• Reviewing for Medical Journal of Islamic World Academy of Sciences journal for the article Retrospective analysis of patients with chronic myeloproliferative neoplasms: a single center experience [cite: 211]
• Reviewing for Medical Journal of Islamic World Academy of Sciences journal for the article Importance of vitamin d level in early-stage chronic lymphocytic leukemia and its comparison with healthy population [cite: 211]
• Reviewing for Turkish Journal of Hematology journal for the article Secondary EBV Related Lymphoma in a Patient with Angioimmunoblastic T Cell Lymphoma: A Case Presentation [cite: 211]
• Reviewing for Revista da Associação Médica Brasileira journal for the article Serum Uric Acid To HDL-Cholesterol Ratio Is A Strong Predictor Of Metabolic Syndrome In Type 2 Diabetes Mellitus [cite: 211]
• Reviewing for BMJ Case Reports journal for the article Adalimumab-induced acute myeloid leukemia with core-binding factor beta gene rearrangement in a patient with Crohn’s disease [cite: 211]

K. Editorial Board Membership in National Peer-Reviewed Scientific Journals

• Serving on the editorial advisory board of Turgut Özal Tıp Merkezi Dergisi [cite: 212]
• Serving on the editorial advisory board of Experimental Biomedical Research Dergisi [cite: 212]

L. Reviewing in National Peer-Reviewed Scientific Journals

• Reviewing for Turgut Özal Tıp Merkezi Dergisi for the article "An aggressive mantle cell lymphoma case" [cite: 214]
• Reviewing for Turgut Özal Tıp Merkezi Dergisi for the article "Case report of extranasal NK cell lymphoma with widespread skin involvement" [cite: 215]
• Reviewing for Turgut Özal Tıp Merkezi Dergisi for the article "Our Haploidentical Transplant Experience at Turgut Özal Tıp Merkezi: Case Report and Literature Presentation" [cite: 216]
• Reviewing for Turgut Özal Tıp Merkezi Dergisi for the article "Bleeding diathesis due to cefoperazone sodium use" [cite: 217]
• Reviewing for LLM (Journal of Leukemia Lymphoma Myeloma Research in Turkey) journal for the article "Retrospective Analysis Comparing Hypomethylating Agents in the Treatment of Myelodysplastic Syndrome; Single Center Experience" [cite: 218]
• Reviewing for Turgut Özal Tıp Merkezi Dergisi for the article "Ascites and hepatic involvement: a rare and atypical presentation of Burkitt Lymphoma" [cite: 219]
• Reviewing for Ankara Training and Research Hospital Medical Journal for the article "Etiological Evaluation of Patients with Venous Thromboembolism" [cite: 219]
• Reviewing for LLM (Journal of Leukemia Lymphoma Myeloma Research in Turkey) journal for the article "Case of Myelodysplastic Syndrome Transformed to Acute Myeloid Leukemia with Der(1) T(1;19) Chromosomal Anomaly Detected in Relapse After Allogeneic Transplantation" [cite: 219]

M. Citations in International Reference Books and Journals

• Total Number of Citations: 124 [cite: 220] h-index: 7 [cite: 220]
• Publication Total number of citations [cite: 220]
• Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates? 10 [cite: 220]
• A Quasi-Experimental Study Analyzing the Effectiveness of Portable High-Efficiency Particulate Absorption Filters in Preventing Infections in Hematology Patients during Construction 12 [cite: 220]
• Impact of PET-CT response on survival parameters following autologous stem cell transplantation among patients with multiple myeloma: comparison of two cut-off values 18 [cite: 221]
• A multi-center study on the efficacy of eltrombopag in management of refractory chronic immune thrombocytopenia: a real-life experience 9 [cite: 222]
• SAPHO Syndrome may be treated effectively with combined drug regimens 7 [cite: 223]
• How confocal laser endomicroscopy can help us in diagnosing gastric lymphomas? 6 [cite: 224]
• Allogeneic transplantation in chronic myeloid leukemia and the effect of tyrosine kinase inhibitors on survival: a quasi-experimental study 9 [cite: 225]
• Is cytomegalovirus a risk factor for haemorrhagic cystitis in allogeneic haematopoietic stem cell transplantation recipients? 7 [cite: 226]
• A Rare Non-Hemolytic Case of Idiopathic Cold Agglutinin Disease 6 [cite: 226]
• Kandidemi saptanan hematolojik kanserli hastalarda etken dağılımı ve risk faktörlerinin değerlendirilmesi (Evaluation of agent distribution and risk factors in hematological cancer patients with candidemia) 5 [cite: 227]
• Subsequent malignancies after allogeneic hematopoietic stem cell transplantation 5 [cite: 227]
• Antilymphocyte/Thymocyte Globulin for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease: 20-Year Experience at a Single Center[cite: 228]. 4 [cite: 228]
• Chimeric Antigen Receptor (CAR) T-cells as a therapeutic modality 2 [cite: 228]
• Estrogen or testosterone may be effective agents in the management of both multiple myeloma and Alzheimer’s disease 4 [cite: 229]
• Autoimmune disease, tumor necrosis factor inhibitors and acute leukemia: possible associations in two patients? 2 [cite: 230]
• Trastuzumab 1-year vs 9-week in early-stage HER2-positive, lymph node negative breast cancer patients 2 [cite: 230]
• Standard blood parameters in anemic patients with cancer and with other diseases 2 [cite: 231]
• Early graft survival after renal transplantation, single center experience 1 [cite: 231]
• Management of Hemorrhagic Cystitis after Allogeneic Hematopoietic Stem Cell Transplantation 1 [cite: 231]
• The effect of age on peripheral stem cell mobilization in healthy donors, single center experience 2 [cite: 231]
• Incomplete Antibodies May Reduce ABO Cross-Match Incompatibility: A Pilot Study 1 [cite: 232]
• Therapeutic plasma exchange ameliorates incompatible crossmatches 1 [cite: 232]
• Antilymphocyte/Thymocyte Globulin for the Treatment of Steroid-Refractory Acute Graft-Versus-Host Disease: 20-Year Experience at a Single Center[cite: 233]. 4 [cite: 233]
• Intraductal trastuzumab treatment may be effective in the management of ductal carcinoma in situ of the breast with HER-2 overexpression 1 [cite: 234]
• Addition of nine weeks of trastuzumab to adjuvant chemotherapy in operable HER2-positive breast cancer patients: Retrospective analysis 1 [cite: 235]
• Lomeguatrib, a O6-Methylguanine-DNA-methyltransferase (MGMT) inhibitor, induces DNA damage induced apoptosis by targeting double-strand DNA repair in multiple myeloma 1 [cite: 236]
• Lung cancer in young patients under the age of thirty-five; single center experience 1 [cite: 236]

N. English Book Chapters

• Özen M, Gündüz M, Haider KH. Chimeric Antijgen Receptor (CAR) T-cells as a therapeutic modality[cite: 238]. Chapter 8 in Stem Cells: From Hype to Hope. Ed: Haider KH. ISBN-10: 9811205523. 2020; 211-236[cite: 239].

O. Turkish Book Chapter

• Özen M, Konuk N. Immune thrombocytopenic purpura[cite: 240]. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition[cite: 240]. Ankara: Türkiye Klinikleri; 2021. p.8-12[cite: 240].
• Özen M, Ural AU. Hematological diseases and mesenchymal stem cell applications[cite: 241]. Türköz Sucak G, editor. Current Topics in Immunohematology. 1st Edition. Ankara: Türkiye Klinikleri; 2021. p.91-4[cite: 241].
• Özen M. Hematopoiesis and Hematopoietic Growth Factors[cite: 242]. MediHealth & Hipokrat INTERNAL MEDICINE 2022 with Current Guidelines. p1607-10 [cite: 242]